News & Events

January 21, 2021
Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board SAN DIEGO, October 19, 2021 – Plexium Inc., a biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, today announced the completion of a $35M financing, led by Lux Capital and Pivotal BioVentures, with […]
October 17, 2019
Funds will help advance Plexium’s DELPhe platform to discover novel E3 ligase-modulating therapeutics to treat cancer and neurodegenerative diseases SAN DIEGO, October 17, 2019 – Plexium today announced the launch of the company with the closing of a $28 million Series A financing. The financing was led by DCVC Bio and The Column Group, with […]
October 9, 2019
Plexium CEO Swamy Vijayan to present at the North American Protein Degradation Congress in San Diego, CA on February 4-5, 2020.
October 8, 2019
Plexium CEO Swamy Vijayan to present at the Targeted Protein Degradation Summit in Boston on October 23, 2019.